Sponsor
Vestre Viken Hospital Trust
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Vestre Viken Hospital Trust appears in 27 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
27 shownINTEgRated Health CARE for Patients With Frailty and Heart FailureNCT06444321 · lead sponsor · 2024-06-06
RECRUITINGEffect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective DisorderNCT06197048 · lead sponsor · 2023-09-25
RECRUITING18F-FDG PET/CT Imaging for Breast CancerNCT05730608 · lead sponsor · 2023-02-16
RECRUITINGEfficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung CancerNCT05344209 · lead sponsor · 2022-08-12
RECRUITINGImproved Diagnostics, Treatment and Follow-up of Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseNCT06105814 · lead sponsor · 2024-01-01
NOT_YET_RECRUITINGRemote Monitoring After Heart FailureNCT05447598 · lead sponsor · 2023-04-25
ACTIVE_NOT_RECRUITINGClinical Pilot Study for Personalized Risk-based Breast Cancer ScreeningNCT05731453 · lead sponsor · 2023-02-01
ACTIVE_NOT_RECRUITINGSotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With ComorbiditiesNCT05311709 · lead sponsor · 2022-05-30
UNKNOWNTelehealth Follow-up in Patients With Rheumatoid ArthritisNCT04536844 · lead sponsor · 2020-06-15
UNKNOWNFirst-line Treatment With Osimertinib in EGFR-mutated Non-small Cell Lung CancerNCT03804580 · lead sponsor · 2018-12-01
UNKNOWNMaternal Metabolism and Pregnancy Outcomes in Obese Pregnant WomenNCT02564250 · lead sponsor · 2015-09-01
UNKNOWNEfficiency of 4-aminopyridin (Fampyra) on Gait, Vision, Cognition, Fatigue and Micturation in Patients With Multiple SclerosisNCT01720849 · lead sponsor · 2012-12-01
UNKNOWNAkershus Cardiac Examination (ACE) 1950 StudyNCT01555411 · lead sponsor · 2012-09-01
ACTIVE_NOT_RECRUITINGSeven-step Phenomenological Psychotherapy for Self-disorder - a Pilot StudyNCT06597864 · collaborator · 2024-10-17
RECRUITINGThe Norwegian Antirheumatic Drug RegisterNCT01581294 · collaborator · 2012-04-01
RECRUITINGPERsonalized Mammographic Screening in NorwayNCT07371702 · collaborator · 2026-01-01
NOT_YET_RECRUITINGEffect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease Control in Adults With Rheumatoid Arthritis on a Subcutaneous TNF Inhibitor: The Rheumatoid Arthritis Therapeutic DRUg Monitoring Trial (RA-DRUM)NCT06440629 · collaborator · 2024-08-20
ACTIVE_NOT_RECRUITINGPlasma Dilution and Infusion to Improve Cognition in Mild Cognitive Impairment (MCI)NCT06234436 · collaborator · 2023-12-07
UNKNOWNNeoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and LetrozoleNCT05163106 · collaborator · 2022-12-01
COMPLETEDEffects of Glucose Lowering Agents in South Asian Women With Impaired Glucose Tolerance or Impaired Fasting GlucoseNCT04662866 · collaborator · 2021-02-10
UNKNOWNLiving Well with Chronic PainNCT03705104 · collaborator · 2019-12-03
ACTIVE_NOT_RECRUITINGNorwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)NCT04121403 · collaborator · 2019-10-16
COMPLETEDImplementation of Family Involvement for Persons With Psychotic Disorders.NCT03869177 · collaborator · 2019-03-21
COMPLETEDAtezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung CancerNCT03540420 · collaborator · 2018-07-31
ACTIVE_NOT_RECRUITINGThe HUNT for Heart Failure" Risk ScoreNCT04648852 · collaborator · 2017-10-01
COMPLETEDA Mobile Smartphone Application to Promote a Healthy Diet and Physical Activity Among Pregnant Women With GDM - RCTNCT02588729 · collaborator · 2015-10-01
COMPLETEDFitness, Activity and Lung Cancer StudyNCT01748981 · collaborator · 2010-11-01
COMPLETEDDrugs studied in this sponsor's trials
5 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing Vestre Viken Hospital Trust as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
atezolizumab1
cladribine1
goserelin1
osimertinib1
sotorasib1
atezolizumab RxCUI 1792776 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
cladribine RxCUI 44157 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
goserelin RxCUI 50610 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
osimertinib RxCUI 1721560 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
sotorasib RxCUI 2550714 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
Sponsor roles
collaborator14
lead sponsor13
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.